OTCMKTS:CVALF Covalon Technologies Q1 2025 Earnings Report $2.95 -0.25 (-7.70%) As of 09/29/2026 02:45 PM Eastern ProfileEarnings History Covalon Technologies EPS ResultsActual EPS$0.03Consensus EPS -$0.03Beat/MissBeat by +$0.06One Year Ago EPSN/ACovalon Technologies Revenue ResultsActual Revenue$5.84 millionExpected Revenue$6.37 millionBeat/MissMissed by -$526.00 thousandYoY Revenue GrowthN/ACovalon Technologies Announcement DetailsQuarterQ1 2025Date2/21/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsCovalon Technologies' next earnings date is estimated for Thursday, December 10, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Covalon Technologies Earnings HeadlinesCovalon Reports Fiscal 2026 Third Quarter ResultsAugust 27, 2026 | businesswire.comCovalon Technologies Ltd CVALFAugust 21, 2026 | morningstar.comMA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the country entirely - as concerns grow about the next phase of the AI market. One AI insider says investors should reassess their positions before September 30, pointing to a critical shift ahead for tech and AI-related stocks. | TradeSmith (Ad)Covalon Technologies Ltd (CVALF) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...May 21, 2026 | finance.yahoo.comCovalon Reports 2026 Second Quarter ResultsMay 21, 2026 | businesswire.comEvidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual MeetingMay 13, 2026 | businesswire.comSee More Covalon Technologies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Covalon Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Covalon Technologies and other key companies, straight to your email. Email Address About Covalon TechnologiesCovalon Technologies (OTCMKTS:CVALF) is a Canadian medical technology company focused on developing and commercializing advanced healthcare products. Its activities center on wound care, infection prevention and surgical applications, with technologies designed to help protect tissue, support healing and improve the management of medical procedures. The company’s product portfolio includes collagen-based wound care products marketed under the ColActive brand, as well as antimicrobial and protective coatings, dressings and other medical devices. Covalon develops technologies for use in hospitals, clinics and other healthcare settings, including products intended to address chronic wounds, surgical wounds and infection-control needs. Covalon serves healthcare providers and patients through commercial relationships with distributors and medical organizations in North America and selected international markets. The company is headquartered in Canada and has historically operated as a publicly traded healthcare technology business under the Covalon name.View Covalon Technologies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles CarMax Just Gave Investors a Better Reason to Believe in the TurnaroundBernstein Downgrades 3 Cybersecurity Stocks: How Concerned Should Investors Be?Brewing Trouble? Starbucks Spills the Beans on 250 Store ClosuresMarketBeat Week in Review – 09/21 - 09/25Analyst Rating Boosts May Signal More Upside for These 3 Stocks3 Stocks Under the Microscope After Large Insider Sales3 Healthcare Stocks Showing Why the Sector Still Has Momentum Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
